HomeCompareVER vs JNJ

VER vs JNJ: Dividend Comparison 2026

VER yields 65.63% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 VER wins by $10.73M in total portfolio value
10 years
VER
VER
● Live price
65.63%
Share price
$51.12
Annual div
$33.55
5Y div CAGR
12.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$10.75M
Annual income
$5,640,171.13
Full VER calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — VER vs JNJ

📍 VER pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodVERJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, VER + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
VER pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

VER
Annual income on $10K today (after 15% tax)
$5,578.83/yr
After 10yr DRIP, annual income (after tax)
$4,794,145.46/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, VER beats the other by $4,793,441.85/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of VER + JNJ for your $10,000?

VER: 50%JNJ: 50%
100% JNJ50/50100% VER
Portfolio after 10yr
$5.39M
Annual income
$2,820,499.46/yr
Blended yield
52.36%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

VER
Analyst Ratings
5
Buy
10
Hold
Consensus: Hold
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

VER buys
0
JNJ buys
0
No recent congressional trades found for VER or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricVERJNJ
Forward yield65.63%3.36%
Annual dividend / share$33.55$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR12.7%5.8%
Portfolio after 10y$10.75M$20.0K
Annual income after 10y$5,640,171.13$827.78
Total dividends collected$10.12M$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusHoldBuy

Year-by-year: VER vs JNJ ($10,000, DRIP)

YearVER PortfolioVER Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$18,097$7,396.87$10,676$355.77+$7.4KVER
2$33,463$14,099.10$11,407$389.39+$22.1KVER
3$63,264$27,459.32$12,198$426.53+$51.1KVER
4$122,373$54,679.95$13,056$467.62+$109.3KVER
5$242,341$111,402.19$13,987$513.12+$228.4KVER
6$491,673$232,367.74$14,998$563.56+$476.7KVER
7$1,022,642$496,552.20$16,098$619.52+$1.01MVER
8$2,182,036$1,087,808.66$17,295$681.69+$2.16MVER
9$4,779,508$2,444,729.58$18,599$750.82+$4.76MVER
10$10,754,245$5,640,171.13$20,022$827.78+$10.73MVER

VER vs JNJ: Complete Analysis 2026

VERStock

VEREIT is a full-service real estate operating company which owns and manages one of the largest portfolios of single-tenant commercial properties in the U.S. The Company has total real estate investments of $14.6 billion including approximately 3,800 properties and 88.9 million square feet. VEREIT's business model provides equity capital to creditworthy corporations in return for long-term leases on their properties. VEREIT is a publicly traded Maryland corporation listed on the New York Stock Exchange. VEREIT uses, and intends to continue to use, its Investor Relations website, which can be found at www.VEREIT.com, as a means of disclosing material nonpublic information and for complying with its disclosure obligations under Regulation FD.

Full VER Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this VER vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

VER vs SCHDVER vs JEPIVER vs OVER vs KOVER vs MAINVER vs ABBVVER vs MRKVER vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.